Primary and additional treatment preference in aggressive retinopathy of prematurity and type 1 retinopathy of prematurity.
Ji Hye JangYong Koo KangHan Sang ParkKiyoung KimSung Soo KimJae Yong HanHyun Wong KimJong Wook BangJae Shin SongSang Jun ParkSe Joon WooKwang Sic JooWoong-Sun YooInyoung ChungYong-Wun ChoJong Hyun LeeHun Jin ChoiYoo Ri ChungPublished in: BMJ open ophthalmology (2023)
In Korea, the preference for anti-VEGF therapy or laser therapy differed according to ROP subtype, zone and primary or secondary treatment. These findings suggest that ROP treatment are considered according to ROP subtype, location and reactivation.